Chad Dunbar
liked
$Unicycive Therapeutics(UNCY.US$
Unicycive Therapeutics Granted Patent on UNI-494 to Treat Acute Kidney Injury by the United States Patent and Trademark Office (USPTO)
Unicycive Therapeutics (Nasdaq: UNCY) has been granted U.S. Patent No. 12,036,211 by the USPTO for UNI-494, ensuring intellectual property protection until 2040. The patent covers a method of treating acute kidney injury or contrast-induced nephropathy using the UNI-494 compound, a novel nicotinamide ester derivative and sele...
Unicycive Therapeutics Granted Patent on UNI-494 to Treat Acute Kidney Injury by the United States Patent and Trademark Office (USPTO)
Unicycive Therapeutics (Nasdaq: UNCY) has been granted U.S. Patent No. 12,036,211 by the USPTO for UNI-494, ensuring intellectual property protection until 2040. The patent covers a method of treating acute kidney injury or contrast-induced nephropathy using the UNI-494 compound, a novel nicotinamide ester derivative and sele...
1
Chad Dunbar
liked
$Unicycive Therapeutics(UNCY.US$ Unicycive Therapeutics Granted Patent on Uni-494 to Treat Acute Kidney Injury by the United States Patent and Trademark Office (Uspto)
2
$Unicycive Therapeutics(UNCY.US$ has until January 6, 2025 to get its closing share price above $1.00 for 10 consecutive days or will face desliting on the NASDAQ CM. the company has also fallen below the $35 million minimum market value and has until January 7, 2025 to get its market value above $35 million for 10 consecutive days or the company will face delisting. The company plans to get its market value above the minimum level in the short term. The company may ei...
$Unicycive Therapeutics(UNCY.US$ Robert Leboyer of Noble Financial reiterated a Buy rating on Unicycive Therapeutics today, with a price target of $6.00.
1
Chad Dunbar
liked
$Unicycive Therapeutics(UNCY.US$ Unicycive Therapeutics Announces Initial Positive Patient Satisfaction Findings From Pivotal Clinical Trial Of Oxylanthanum Carbonate (OLC) - Company Says Patients Preferred OLC More Than 4 To 1 Over Prior Phosphate Binder Therapy
1
$Unicycive Therapeutics(UNCY.US$ has finalized an order for the manufacture of OLC tablets to be completed and delivered by June 30, 2025. Another tranch of tablets will be ordered and delivered sometime between December 31, 2025 and June 30, 2026.
Chad Dunbar
reacted to
If you watch the presidental debate today, you see Trump absolutely destroy Biden on the debate. Biden's clumsy speech, worried voters and supporter about his health and age to run as president. ![]()
![]()
![]()
Not only Trump seems to claim victory over the media, his stock $Trump Media & Technology(DJT.US$ jumped 12% on pre-market, claiming victory for investors as well lol.
I did said in the previous post about this...
Not only Trump seems to claim victory over the media, his stock $Trump Media & Technology(DJT.US$ jumped 12% on pre-market, claiming victory for investors as well lol.
I did said in the previous post about this...
13
3
Chad Dunbar
voted
Morning traders! Happy Friday, June 28th. Investors are reacting to the Trump Biden debate, which to me, felt like two old men were angry at bingo night at the old folks home.
My name is Kevin Travers; here are stories from the moomoo herd on Wall Street today.
$Nike(NKE.US$ fell 15% after reporting earnings Thursday, meeting EPS expectations but announcing weak guidance for the coming quarter...
My name is Kevin Travers; here are stories from the moomoo herd on Wall Street today.
$Nike(NKE.US$ fell 15% after reporting earnings Thursday, meeting EPS expectations but announcing weak guidance for the coming quarter...
![Investors Wake up to Advancing Market After Presidential Debate and PCE Unchanged | Herd on Wall Street](https://1500015405.vod2.myqcloud.com/edcaf1cfvodtransca1500015405/b365203e1397757888169183482/coverBySnapshot/coverBySnapshot_10_0.jpg)
29
28
$Unicycive Therapeutics(UNCY.US$ This big drop is partially due to a reverse stock split that is coming soon. The stock price has closed below $1.00 since May 23rd. Despite the good news on the drug trials, Unicycive will need to raise the stock price in order to remain listed on the NasdaqCM…and this means a reverse stock split. Investors on trading platforms like Morgan Stanley, E*Trade, and TD Ameritrade are probably dumping their shares to avoid a $38.00 reorgani...
2